Stevens Capital Management’s Novo Nordisk NVO Stock Holding History

Stevens Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$641K	Sell	13,363 -178,373	-93%	-$7.66M	0.15%	122
2026 Q1	$7.05M	Buy	+191,736	New	+$9.08M	1.09%	23
2020 Q3	–	Sell	-17,958	Closed	-$588K	–	168
2020 Q2	$588K	Buy	+17,958	New	+$573K	0.22%	60
2020 Q1	–	Sell	-18,204	Closed	-$527K	–	299
2019 Q4	$527K	Buy	+18,204	New	+$504K	0.05%	343
2018 Q3	–	Sell	-8,766	Closed	-$202K	–	888
2018 Q2	$202K	Buy	+8,766	New	+$208K	0.01%	704
2017 Q4	–	Sell	-9,324	Closed	-$224K	–	975
2017 Q3	$224K	Buy	+9,324	New	+$211K	0.01%	735
2017 Q2	–	Sell	-13,204	Closed	-$226K	–	999
2017 Q1	$226K	Buy	+13,204	New	+$230K	0.01%	747
2016 Q4	–	Sell	-69,008	Closed	-$1.44M	–	1036
2016 Q3	$1.44M	Buy	69,008 +22,230	+48%	+$551K	0.06%	344
2016 Q2	$1.26M	Buy	+46,778	New	+$1.28M	0.05%	383
2015 Q1	–	Sell	-38,384	Closed	-$812K	–	1151
2014 Q4	$812K	Buy	+38,384	New	+$857K	0.03%	471
2014 Q2	–	Sell	-14,440	Closed	-$330K	–	1237
2014 Q1	$330K	Sell	14,440 -21,850	-60%	-$466K	0.01%	767
2013 Q4	$670K	Sell	36,290 -95,250	-72%	-$1.66M	0.02%	565
2013 Q3	$2.23M	Sell	131,540 -33,880	-20%	-$570K	0.07%	321
2013 Q2	$2.56M	Buy	+165,420	New	+$2.75M	0.09%	261

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Stevens Capital Management's NVO Position: Q2 2026 in Review

Stevens Capital Management reduced its Novo Nordisk (NVO) stake by 93% in Q2 2026, selling an estimated $7.66M and leaving 13,363 shares worth $641K. The position accounts for 0.15% of the portfolio, ranked #122.

Stevens Capital Management first reported a position in NVO in Q2 2013 and has held it in 14 quarters since. The position peaked at $7.05M in Q1 2026. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Stevens Capital Management held 13,363 shares of Novo Nordisk worth $641K as of Q2 2026.
Stevens Capital Management sold 178,373 Novo Nordisk shares in Q2 2026, an estimated $7.66M.
Novo Nordisk made up 0.15% of Stevens Capital Management's portfolio in Q2 2026, its #122 holding.
Stevens Capital Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 14 quarters since.
Stevens Capital Management's Novo Nordisk position peaked at $7.05M in Q1 2026.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Stevens Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.